Suboxone Settlement Payments Finally Coming -- Court Approved Distribution, Checks Expected Within 30 Days
By Steve Levine
Published: March 25, 2026
After years of waiting, the Suboxone antitrust settlement is finally moving toward payment. On March 18, 2026, the court entered an order approving the distribution of the settlement fund. The official settlement website at SuboxAntitrust.com now states that the settlement administrator has begun processing and that distribution is anticipated within approximately 30 days -- putting the expected payment window around mid-April 2026.
If you filed a valid claim in this settlement by the February 17, 2024 deadline, your payment is finally on the way. If you did not file a claim, the deadline has passed and you cannot participate.
This is the $30 million Suboxone indirect purchaser (consumer) antitrust settlement. The case -- In Re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation -- alleged that Indivior (formerly Reckitt Benckiser Pharmaceuticals) and other defendants conspired to block generic competition for Suboxone, the widely used opioid addiction treatment drug. By keeping generics off the market, the defendants allegedly forced consumers to pay inflated prices for Suboxone for years.
Indivior denied all wrongdoing but agreed to pay $30 million into a settlement fund for indirect purchasers -- meaning the consumers and insurance companies that ultimately paid for the drug. The settlement received final court approval on December 4, 2023. The claim deadline was February 17, 2024.
For the full breakdown of this settlement, see our Suboxone Class Action Settlement page.
The settlement was approved in December 2023 and the claim deadline was February 2024 -- so why are payments just now being distributed more than two years later? The short answer is that claim review, appeals, and court approval of the final distribution plan all take time, especially in a complex antitrust case with multiple classes of claimants.
The $30 million fund is divided into multiple pools. There is a "Repealer" pool and a "non-Repealer" pool (based on which states' laws apply to each claimant), and each pool is further split 45% to consumers and 55% to third-party payors (insurance companies, health plans, etc.). There were also disputed and denied claims that required judicial review, which added delays. Two attorney withdrawal motions were filed as recently as February 26, 2026, adding to the last-minute procedural activity.
But as of March 18, 2026, the court has given the green light. The administrator is processing payments now.
Individual payment amounts have not been officially announced. However, based on the fund structure, the consumer portion of the settlement is significantly smaller than the total $30 million figure might suggest. The Repealer consumer pool is approximately $6.75 million and the non-Repealer consumer pool is approximately $750,000. The remaining 55% of each pool goes to third-party payors.
Based on analysis shared by claimants, individual consumer payments are estimated at approximately $750 per person, though actual amounts will vary depending on each claimant's qualifying purchases and which pool they fall into. Some claimants may receive more and some may receive less.
No. The claim deadline was February 17, 2024. It has passed. No new claims are being accepted. This payment update only applies to people who already filed valid claims before the deadline.
There is frequent confusion between the Suboxone antitrust settlement and the Suboxone tooth decay lawsuits, and they are completely separate cases.
The antitrust settlement (this one) is about Indivior blocking generic competition to keep Suboxone prices artificially high. It affects consumers who overpaid for the drug between 2011 and 2023. The claim deadline has passed and payments are now being distributed.
The tooth decay lawsuits (MDL 3092, consolidated in the Northern District of Ohio) are about Indivior allegedly failing to warn users that Suboxone sublingual film could cause severe dental problems including tooth decay, tooth loss, and fractures. Over 1,800 individual lawsuits have been filed. Bellwether trials are being scheduled but no settlement has been reached and no claim form exists for the tooth decay cases.
If you suffered dental problems from Suboxone and want to pursue a claim, that is a separate legal matter. Consult a personal injury attorney who handles pharmaceutical litigation.
The $30 million consumer settlement is just one piece of Indivior's legal reckoning. The company (and its predecessor Reckitt Benckiser) have faced massive legal consequences for their conduct related to Suboxone. In 2019, Reckitt Benckiser settled with the U.S. Department of Justice for $1.4 billion over deceptive marketing. In 2020, Indivior paid $600 million for criminal and civil liability related to illegal practices to increase prescriptions. A separate $385 million settlement was reached with direct purchasers (wholesalers and pharmacies) in 2024. And the FTC previously returned approximately $60 million to consumers who were overcharged for Suboxone.
The $30 million indirect purchaser settlement is the consumer-facing piece of this puzzle, and after years of legal proceedings, payments are finally arriving.
If you filed a claim before the February 17, 2024 deadline, there is nothing you need to do. The administrator is processing payments and distribution is expected within approximately 30 days of March 18, 2026. Watch for your payment via the method you selected when you filed your claim -- likely a check, prepaid card, or direct deposit.
If you have questions about your claim status, visit the official settlement website at SuboxAntitrust.com.
For the full details on this settlement, visit our Suboxone Class Action Settlement page.
How Do I Find Class Action Settlements?
Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:
Sources
• Official Settlement Website -- SuboxAntitrust.com (March 18, 2026 distribution order update)
• OpenClassActions -- Suboxone Class Action Settlement Full Details
About This Article
This article is a payment status update for an existing settlement. The claim deadline for this settlement passed on February 17, 2024. No new claims are being accepted. OpenClassActions.com is a consumer advocacy and class action news site, and is not a class action administrator or a law firm.
For more class actions keep scrolling below.